Literature DB >> 14255592

IDIOPATHIC LIPAEMIA RETINALIS.

J F CULLEN, W D CONACHER.   

Abstract

Keywords:  ANTICHOLESTEREMIC AGENTS; BLOOD CHEMICAL ANALYSIS; BLOOD LIPIDS; DRUG THERAPY; HYPERLIPEMIA; OPHTHALMOSCOPY; RETINAL VESSELS

Mesh:

Substances:

Year:  1965        PMID: 14255592      PMCID: PMC506053          DOI: 10.1136/bjo.49.1.11

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  [Retinal lipemia in diabetics].

Authors:  M APPELMANS; J MICHIELS; L JAMOTTON; J M MASSA
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1961 Jan-Feb

2.  A STUDY OF THE EFFECT OF ATROMID THERAPY IN EXUDATIVE DIABETIC RETINOPATHY.

Authors:  J T IRELAND; J F CULLEN; M F OLIVER; L J DUNCAN
Journal:  J Atheroscler Res       Date:  1963 Sep-Dec

3.  [Retinal lipemia].

Authors:  D GODDE-JOLLY; P BONNIN
Journal:  Ann Ocul (Paris)       Date:  1961-08

4.  Ocular manifestations in idiopathic hyperlipaemia and xanthomatosis.

Authors:  P K THOMAS; E B SMITH
Journal:  Br J Ophthalmol       Date:  1958-08       Impact factor: 4.638

5.  Lipemia retinalis; report of a case in a diabetic child aged twenty-eight months and review of the literature.

Authors:  H W LAWS; E R HARPUR
Journal:  AMA Arch Ophthalmol       Date:  1958-04

6.  Idiopathic lipemia retinalis.

Authors:  W S DAVIES
Journal:  AMA Arch Ophthalmol       Date:  1955-01

7.  Nondiabetic lipemia retinalis; report of a case.

Authors:  W G EVERETT
Journal:  AMA Arch Ophthalmol       Date:  1952-12

8.  Reduction of serum-lipid and uric-acid levels by an orally active androsterone.

Authors:  M F OLIVER
Journal:  Lancet       Date:  1962-06-23       Impact factor: 79.321

9.  Ocular conditions associated with idiopathic hyperlipemia.

Authors:  E B DUNPHY
Journal:  Am J Ophthalmol       Date:  1950-10       Impact factor: 5.258

10.  Nondiabetic lipemia retinalis.

Authors:  J J GROOM; C W RUCKER
Journal:  Am J Ophthalmol       Date:  1950-08       Impact factor: 5.258

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.